Technology News and Research

RSS

Study redefines picobirnavirus as a bacteria hunting virus

Thriving alongside trillions of bacteria in the human digestive tract is a vast population of viruses. Ever since one such denizen of the gut microbiome, known as picobirnavirus, was first spotted decades ago, researchers thought it directly infected human tissue and played a role in gastrointestinal illness.

29 Oct 2026

New smartphone patch accurately measures heart health without electronics

The patch is the first of its kind in the world and can assess a patient’s heart condition when combined with an ordinary smartphone.

29 Oct 2026

MIT researchers track muscle movement using tiny magnetic beads

MIT researchers have shown that they can accurately track muscle movement using tiny magnetic beads implanted in the muscle.

29 Oct 2026

Kyushu University and Cipher Core join forces to launch preventive healthcare pilot in Bangladesh

Kyushu University and Cipher Core, a Japanese information security company providing security and financial technology solutions, have signed a joint-research agreement and begun preparations for a preventive healthcare pilot in Bangladesh under the Healthy Bangladesh initiative.

29 Oct 2026

New iron contrast agent offers safer cardiac MRI scans

The Biomolecular Nanotechnology research group led by Ikerbasque research professor Aitziber L. Cortajarena from CIC biomaGUNE has developed a new iron-based contrast agent for magnetic resonance imaging that can be used for both diagnosis and treatment.

29 Oct 2026

Bedfont® Scientific strengthens its commitment to respiratory clinical research

Bedfont® Scientific Limited, a world leader in breath analysis with 50 years of experience manufacturing medical devices, has quietly supported respiratory research around the world and is set to make its debut at its first clinical trial-focused event in November, taking the next step toward a dedicated focus on supporting clinical trials and clinical research teams, marking the beginning of a new chapter at Bedfont®.

From NObreath 29 Oct 2026

Insights into enzyme selectivity open new pathways for pharmaceutical synthesis

Enzymes are the molecular tools of life. They accelerate chemical reactions and are able to distinguish very precisely between molecules that are similar to one another. The high selectivity of many enzymes is key to the production of important medicines such as penicillin and cyclosporine. But how did enzymes develop this ability to distinguish between similar chemical functionalities with such precision.

29 Oct 2026

Ancient protein model shows early steps in energy metabolism

Researchers in Japan engineered ancestral nucleoside diphosphate kinase variants with restricted amino acid repertoires to explore alternative catalytic functions. One variant, Arc1-12KR, retained its protein fold despite lacking catalytic histidine and unexpectedly converted two ADP molecules into ATP and AMP. The findings reveal alternative catalytic potential in simplified proteins and offer clues to possible routes of energy metabolism during early protein evolution.

29 Oct 2026

ATCC selected by ARPA-H to support next-generation BioStabilization technologies

ATCC has been selected by the Advanced Research Projects Agency for Health (ARPA-H) as an affiliate to provide independent verification and validation (IV&V) for its BioStabilization Systems (BoSS) program.

From ATCC 29 Oct 2026

New microscopy platform enables deeper brain imaging without tissue damage

As light travels deeper into the brain, it scatters. Three-photon microscopy, the current state of the art, reduces the resulting background fluorescence and can, in principle, image much deeper than earlier techniques-but to do that, it uses average laser power limits that cause overheating and damage living tissue.

28 Oct 2026

Soft robotic enteroscope offers a new approach to small intestine examination

An innovative robotic device inspired by snake movement could someday help gastroenterologists diagnose and treat inflammatory bowel disease (IBD) and other disorders of the small intestine and remove small polyps while reducing trauma to the organ's delicate tissues.

28 Oct 2026

Ohio State treats Midwest’s first patient in a trial of novel ventricular tachycardia device

The Ohio State University Wexner Medical Center is the first center in the Midwest to enroll and treat a patient in a new clinical trial using a novel device designed to treat recurrent ventricular tachycardia (VT), a serious heart rhythm disorder.

28 Oct 2026

AGS initiative targets gaps in older adults' vaccination rates

Today, the American Geriatrics Society (AGS) released a paper in the Journal of the American Geriatrics Society detailing findings from the AGS Older Adults Vaccine (AGS OAV) Initiative (https://doi.org/10.1111/jgs.70770).

28 Oct 2026

Limited app use adds a twist to a nurse-led dementia risk trial

A cluster-randomized trial involving 403 Australian adults aged 45–65 found that a 12-month nurse-led behavioral intervention supported by a mobile app modestly improved estimated dementia risk scores compared with brief counseling and usual care. The study found no significant improvements in cognitive performance or other secondary outcomes, leaving its long-term effects on dementia prevention uncertain.

28 Oct 2026

Landmark studies map how genetic differences drive human diseases

In three landmark studies published in Nature today, Australian researchers have made major advances in our understanding of how genetic differences between people influence disease.

28 Oct 2026

Macromolecular crowding helps control synthetic DNA droplet formation

Macromolecular crowding can serve as a design tool for controlling the formation and organization of synthetic DNA droplets, a study from Science Tokyo reveals.

28 Oct 2026

New portable device enables fast and accurate detection of PFAS in water

Per- and polyfluoroalkyl substances (PFAS) are synthetic chemicals known for their exceptional resistance to degradation, earning them the nickname "forever chemicals."

28 Oct 2026

Adalvo expands biosimilars portfolio through acquisition of romiplostim biosimilar program from Enzene

Adalvo today announced the acquisition of a romiplostim biosimilar program referencing Nplate® from Enzene, strengthening its biosimilars portfolio and accelerating the company’s expansion into complex biological medicines.

From Adalvo 28 Oct 2026

Prolific announces major new investments and partnerships with NantWorks and Zylidac Bio CDMO

On the heels of our exciting major investment and Nantworks partnership announcement last week, Prolific Machines is pleased to announce a great new partnership with Zylidac Bio, a fully integrated biologics CDMO located next door to us in San Francisco Bay Area, to scale up the production of Prolific's Optogentics-enabled cell lines for clinical and GMP manufacturing!

From Prolific Machines, Inc. 28 Oct 2026

NIOX® launches NIOX PRO®, their next generation FeNO testing device

NIOX Group plc, a global leader in fractional exhaled nitric oxide (FeNO) testing, has announced the launch of NIOX PRO®, its next-generation FeNO testing device designed to support healthcare professionals in the diagnosis and management of asthma, COPD and other inflammatory airway diseases.

From NIOX Group PLC 28 Oct 2026